Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
A vaccine expert explains that such answers likely won’t come until a vaccine has already been approved and administered to millions of people.
Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases

A vaccine expert explains that such answers likely won’t come until a vaccine has already been approved and administered to millions of people.

A vaccine expert explains that such answers likely won’t come until a vaccine has already been approved and administered to millions of people.

coronavirus
First Responders: SARS-CoV-2 and the Immune System
First Responders: SARS-CoV-2 and the Immune System
The Scientist Creative Services Team | Oct 29, 2020
Angela Rasmussen and Ya-Chi Ho explore the positive and negative aspects of the host immune response to SARS-CoV-2 infection and discuss how this knowledge influences therapeutic benefits.
Ferret Study Reinforces Role of Aerosols in SARS-CoV-2 Spread
Ferret Study Reinforces Role of Aerosols in SARS-CoV-2 Spread
Max Kozlov | Oct 28, 2020
Using an elaborate apparatus, researchers find that the virus spreads via aerosolized particles between ferrets more than a meter apart.
Alterations in Immune Genes Make Bats Great Viral Hosts
Alterations in Immune Genes Make Bats Great Viral Hosts
Abby Olena | Oct 27, 2020
Bat species use different strategies to dampen immune activation in response to viruses.
Eli Lilly Halts Antibody Trial in Hospitalized COVID-19 Patients
Eli Lilly Halts Antibody Trial in Hospitalized COVID-19 Patients
Ashley Yeager | Oct 27, 2020
Recent data show that the drug bamlanivimab, also known as LY-CoV555, does not appear to help those with severe cases of COVID-19, but trials continue for milder cases.
More SARS-CoV-2 Reinfections Reported, But Still a Rare Event
More SARS-CoV-2 Reinfections Reported, But Still a Rare Event
Ashley Yeager | Oct 26, 2020
Repeat COVID-19 cases could offer clues about people’s immunity to the novel coronavirus and how to vaccinate against it.
SARS-CoV-2 Disables Key Components of Human Cells’ Defense System
SARS-CoV-2 Disables Key Components of Human Cells’ Defense System
Catherine Offord | Oct 22, 2020
Researchers detail how viral proteins interact with host RNA to disrupt the cell’s ability to fight back against infection.
Decoy Cells Trick SARS-CoV-2, Reduce Cytokines In Vitro
Decoy Cells Trick SARS-CoV-2, Reduce Cytokines In Vitro
Max Kozlov | Oct 14, 2020
Genetically engineered cells that overproduce ACE2, the receptor the novel coronavirus uses to enter cells, neutralize infection in vitro and mop up inflammatory cytokines in mice.
US Tops List of COVID-19 and All-Cause Death Rates Since May
US Tops List of COVID-19 and All-Cause Death Rates Since May
Max Kozlov | Oct 14, 2020
The authors of a new analysis conclude that tens of thousands of lives could have been saved with a more coordinated national response to the coronavirus.
Johnson & Johnson Pauses COVID-19 Vaccine Trials
Johnson & Johnson Pauses COVID-19 Vaccine Trials
Amanda Heidt | Oct 13, 2020
The company voluntarily paused its studies, including one in Phase 3, after an unexplained illness in a patient.